US5707962A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Compositions with enhanced osteogenic potential, method for making the same and therapeutic uses thereof
Assignee: Gensci Regeneration Sciences Inc
•
Filing: 1994-09-28
•
Granted: 1998-01-13
•
Expires: 2014-09-28
Abstract
Abstract The present invention provides improved osteogenic compositions having enhanced by the sorption of growth factors, of nutrient factors, or drugs onto or into the compositions. Compositions may consist of collagen and demineralized bone materials onto and into which growth factors, antimicrobial agent, a nutrient factors, or other soluble factors may be sorbed to enhance the osteogenic factor. These materials can be used in a wide range of clinical procedures to replace and restore osseous or periodontal defects.
Inventors
- 👤 Charles C. Chen
- 👤 Steven R. Jefferies
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 09:12
CPC Classifications
A; A61; A61L; A61L31/00; A61L31/14; A61L31/146; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/18; A61K38/1841; A61K38/1875; A61K6/00; A61K6/80; A61K6/802; A61K6/831; A61K6/838; A61K6/884; A61K6/891; A61L31/04; A61L31/043; A61L31/044; A61L31/047; A61L31/12; A61L31/125; A61L31/127; Y; Y10; Y10S; Y10S128/00; Y10S128/08; Y10S530/00; Y10S530/827; Y10S530/84
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
62 words
A porous or semi-porous osteogenic composition comprising a porous or semiporous matrix of an organic or inorganic material and at least one osteogenic factor, wherein at least one agent selected from the group consisting of growth factors, nutrient factors, drugs, antimicrobial agents, calcium containing compounds, blood proteins or products, and anti-inflammatory agents is sorbed into or onto the porous or semi-porous matrix.
Claim 2
Dependent Claim
62 words
A porous or semi-porous osteogenic composition comprising a porous or semiporous matrix of an organic or inorganic material and at least one osteogenic factor, wherein at least one agent selected from the group consisting of growth factors, nutrient factors, drugs, antimicrobial agents, calcium containing compounds, blood proteins or products, and anti-inflammatory agents is sorbed into or onto the porous or semi-porous matrix.
Claim 3
Dependent Claim
23 words
The composition of claim 1 wherein said nutrient factor is selected from the group consisting of vitamins, cell culture media, and amino acids.
Claim 4
Dependent Claim
27 words
The composition of claim 1 wherein said calcium containing compound is selected from the group consisting of calcium hydroxide, calcium phosphates, calcium lactate and organic calcium salts.
Claim 5
Dependent Claim
18 words
The composition of claim 1 wherein said drugs are selected from the group consisting of tetracycline and metronidazole.
Claim 6
Dependent Claim
20 words
The composition of claim 1 wherein said antimicrobial agent is selected from the group consisting of chlorahexadine and zinc citrate.
Claim 7
Dependent Claim
24 words
The composition of claim 1 wherein said porous or semi-porous matrix is collagen and said osteogenic factor is one or more Bone Morphogenetic Protein.
Claim 8
Dependent Claim
20 words
The composition of claim 6 wherein the composition is in the form of a porous particle, fleece, membrane, or fiber.
Claim 9
Dependent Claim
37 words
The composition of claim 1 in which the growth factor is selected from the group consisting of fibroblast growth factor, transforming growth factors alpha and beta, insulin-like growth factor, nerve growth factor and platelet derived growth factor.
Claim 10
Dependent Claim
15 words
The composition of claim 8 wherein said Transforming Growth Factor-Beta is Transforming Growth Factog-Beta 2.
Claim 11
Dependent Claim
21 words
The composition of claim 1, wherein said porous or semi-porous matrix is collagen and said osteogenic factor is demineralized bone particles.
Claim 12
Dependent Claim
21 words
The composition of claim 10 wherein said composition is in the form of a sponge, porous particles, fleece, membrane or fiber.
Claim 13
Dependent Claim
13 words
The composition of claim 10 in which the composition is a sponge form.
Claim 14
Dependent Claim
27 words
A method of treating an osseous defect in a subject or periodontal defect by implanting the composition of claim 1 to the osseous defect or periodontal defect.
Claim 15
Independent Claim
69 words
A method of making an osteogenic composition having enhanced osteogenic potential comprising: (a) forming a porous or semi-porous matrix of an inorganic or organic material and at least one osteogenic factor; and (b) sorbing at least one agent selected from the group consisting of growth factors, nutrient factors, drugs, antimicrobial agents, calcium containing compounds, blood proteins or products or anti-inflammatory agents into or onto said porous and semi-porous matrix.
Claim 16
Independent Claim
69 words
A method of making an osteogenic composition having enhanced osteogenic potential comprising: (a) forming a porous or semi-porous matrix of an inorganic or organic material and at least one osteogenic factor; and (b) sorbing at least one agent selected from the group consisting of growth factors, nutrient factors, drugs, antimicrobial agents, calcium containing compounds, blood proteins or products or anti-inflammatory agents into or onto said porous and semi-porous matrix.
Claim 17
Dependent Claim
14 words
The method of claim 11 wherein said growth factor is Transforming Growth Factor-Beta 2.
References Cited (Backward Citations)
US2516438A
Cited
US3767437A
Cited
US4209434A
Cited
US4172128A
Cited
US4193813A
Cited
US4291013A
Cited
US4294753A
Cited
US4789732A
Cited
US4619989A
Cited
US4472840A
Cited
US4394370A
Cited
US4430760A
Cited
US4440750A
Cited
US4485097A
Cited
US4642120A
Cited
US4434094A
Cited
US4563489A
Cited
US4703108A
Cited
US4596574A
Cited
US4623553A
Cited
US4620327A
Cited
US4627982A
Cited
US4563350A
Cited
US4795467A
Cited
US4678470A
Cited
US4681763A
Cited
US4718910A
Cited
US5002583A
Cited
US4743259A
Cited
WO1989004646A1
Cited
US5073114A
Cited
US5207710A
Cited
US5264214A
Cited
US5236456A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-01-12 | 2001-07-14 | 2002-01-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-01-12 | 2005-07-14 | 2006-01-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-01-12 | 2009-07-14 | 2010-01-13 | $7700.00 | Window Closed / Lapsed |